In particular, clinical studies have shown that IL-1β concentrations are significantly increased in the bronchoalveolar lavage (BAL) and sputum of people with CF, and IL-1β polymorphisms are linked with disease severity [4,5,6,7]. The gene discussed is IL1B; the disease is cystic fibrosis.